Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation

Nature
R BaskaranJ Y Wang

Abstract

Ataxia telangiectasia (AT) is a rare human autosomal recessive disorder with pleiotropic phenotypes, including neuronal degeneration, immune dysfunction, premature ageing and increased cancer risk. The gene mutated in AT, ATM, encodes a putative lipid or protein kinase. Most of the human AT patient phenotypes are recapitulated in Atm-deficient mice. Cells derived from Atm-/- mice, like those from AT patients, exhibit abnormal response to ionizing radiation. One of the known responses to ionizing radiation is the activation of a nuclear tyrosine kinase encoded by the c-abl proto-oncogene. Ionizing radiation does not activate c-Abl in cells from AT patients or in thymocytes or fibroblasts from the Atm-deficient mice. Ectopic expression of a functional ATM kinase domain corrects this defect, as it phosphorylates the c-Abl tyrosine kinase in vitro at Ser 465, leading to the activation of c-Abl. A mutant c-Abl with Ser 465 changed to Ala 465 is not activated by ionizing radiation or ATM kinase in vivo. These findings identify the c-Abl tyrosine kinase as a downstream target of phosphorylation and activation by the ATM kinase in the cellular response to ionizing radiation.

References

Oct 1, 1989·Molecular and Cellular Biology·A J FornaceN J Holbrook
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R B Painter, B R Young
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R BaskaranJ Y Wang
Jul 12, 1996·Cell·C BarlowA Wynshaw-Boris
Jan 1, 1996·Human Molecular Genetics·P J ByrdA M Taylor
Apr 1, 1996·Human Molecular Genetics·S GiladA Bar-Shira
Apr 1, 1997·Molecular and Cellular Biology·S E MorganM B Kastan

❮ Previous
Next ❯

Citations

Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·A WahaR K Schmutzler
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·S LinardopoulosA Balmain
Nov 18, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·G Rotman, Y Shiloh
Apr 25, 2000·Indian Journal of Pediatrics·H P Wagner
May 10, 2001·International Journal of Hematology·Y Maru
Nov 26, 2008·Journal of Applied Genetics·Kamila CzornakKrystyna H Chrzanowska
Jan 22, 2009·Apoptosis : an International Journal on Programmed Cell Death·Xiang HeHui Zhong
Mar 17, 2006·Breast Cancer Research and Treatment·Geneviève Vaudan VutskitsAndré-Pascal Sappino
Dec 10, 2002·Biochemical and Biophysical Research Communications·Yingzhu LiKen-ichi Yamamoto
Apr 25, 2003·Experimental and Molecular Pathology·Alexander J R Bishop, Robert H Schiestl
May 30, 2001·Mutation Research·L H Thompson, D Schild
Nov 13, 2002·Mutation Research·Larry H Thompson, David Schild
Jun 7, 2003·Advances in Enzyme Regulation·Hans H GrunickeFlorian Ueberall
Oct 2, 2003·Brain Research. Developmental Brain Research·Heather L MillerPeter J McKinnon
Jan 13, 1998·Biochimica Et Biophysica Acta·A B RaitanoC L Sawyers
Jun 30, 1998·Ryōikibetsu shōkōgun shirīzu·T FukaoN Kondo
Mar 10, 2001·International Journal of Radiation Oncology, Biology, Physics·L LiR J Legerski
May 31, 2001·International Journal of Radiation Oncology, Biology, Physics·S TribiusD Casper
May 15, 2002·Journal of Pharmaceutical and Biomedical Analysis·Anastasia Zotou, Niki Miltiadou
Apr 30, 1998·Current Opinion in Cell Biology·J Y Wang
Sep 24, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W Jongmans, J Hall
Aug 9, 2003·Current Biology : CB·Richard A Van Etten
Aug 8, 1998·Trends in Cell Biology·X Tan, J Y Wang
May 14, 1999·Trends in Cell Biology·R A Van Etten
Apr 27, 2000·Trends in Biochemical Sciences·R BosottiE L Sonnhammer
Apr 18, 2000·Mutation Research·S Angèle, J Hall
Jan 3, 2003·Mutation Research·Jun YangPenelope J Duerksen-Hughes
Jul 11, 2013·Chemical Reviews·Célia JeronimoFrançois Robert
Aug 28, 2010·Cell Death and Differentiation·X WangB Li
Dec 15, 2010·Cell Death and Differentiation·V MeltserY Shaul

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.